These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2643773

  • 1. Improvement of renal function with selective thromboxane antagonism in lupus nephritis.
    Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Patrignani P, Ciabattoni G, Patrono C.
    N Engl J Med; 1989 Feb 16; 320(7):421-5. PubMed ID: 2643773
    [Abstract] [Full Text] [Related]

  • 2. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T, Kameda H, Ichikawa Y, Tojo T, Homma M.
    J Rheumatol; 1996 Oct 16; 23(10):1719-24. PubMed ID: 8895147
    [Abstract] [Full Text] [Related]

  • 3. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS, Jones SL, Barrow SE, Stratton PD, Alessandrini P, De Cosmo S, Ritter JM, Viberti GC.
    J Lab Clin Med; 1993 Mar 16; 121(3):415-23. PubMed ID: 8445289
    [Abstract] [Full Text] [Related]

  • 4. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ, Mayo G, Price P, FitzGerald GA.
    N Engl J Med; 1991 Oct 17; 325(16):1137-41. PubMed ID: 1891022
    [Abstract] [Full Text] [Related]

  • 5. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A.
    J Clin Invest; 1985 Sep 17; 76(3):1011-8. PubMed ID: 3900132
    [Abstract] [Full Text] [Related]

  • 6. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R.
    N Engl J Med; 1989 Aug 10; 321(6):357-62. PubMed ID: 2664523
    [Abstract] [Full Text] [Related]

  • 7. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P, Arnout J, Deckmyn H, Huybrechts E, Pieters G, Vermylen J.
    J Clin Invest; 1987 Nov 10; 80(5):1435-45. PubMed ID: 2960694
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ.
    N Engl J Med; 1981 Jan 08; 304(2):76-9. PubMed ID: 7003384
    [Abstract] [Full Text] [Related]

  • 9. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Yoshida T, Ichikawa Y, Tojo T, Homma M.
    Lupus; 1996 Apr 08; 5(2):129-38. PubMed ID: 8743126
    [Abstract] [Full Text] [Related]

  • 10. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb 08; 64(2):95-103. PubMed ID: 11237476
    [Abstract] [Full Text] [Related]

  • 11. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.
    Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C.
    N Engl J Med; 1984 Feb 02; 310(5):279-83. PubMed ID: 6361565
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C.
    J Lab Clin Med; 1989 May 02; 113(5):549-60. PubMed ID: 2541212
    [Abstract] [Full Text] [Related]

  • 14. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M, Benigni A, Zoja C, Begnis R, Morelli C, Rossini M, Garattini S, Remuzzi G.
    J Pharmacol Exp Ther; 1989 Jan 02; 248(1):334-41. PubMed ID: 2492341
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
    Stork JE, Dunn MJ.
    J Pharmacol Exp Ther; 1985 Jun 02; 233(3):672-8. PubMed ID: 3859644
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P.
    Clin Pharmacol Ther; 2006 Sep 02; 80(3):264-74. PubMed ID: 16952493
    [Abstract] [Full Text] [Related]

  • 17. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
    Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA.
    N Engl J Med; 1986 Apr 10; 314(15):937-42. PubMed ID: 3007982
    [Abstract] [Full Text] [Related]

  • 18. Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes.
    Farker K, Merkel U, Schweer H, Haerting J, Madani SF, Eggers R, Müller UA, Seyberth HW, Hoffmann A.
    Eur J Clin Pharmacol; 2002 May 10; 58(2):85-91. PubMed ID: 12012138
    [Abstract] [Full Text] [Related]

  • 19. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA, Minar E, Brenner B, Eichler HG, Heistinger M, Marosi L, Lechner K.
    Thromb Haemost; 1989 Jun 30; 61(3):374-7. PubMed ID: 2508252
    [Abstract] [Full Text] [Related]

  • 20. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
    Ottesen LH, Aagaard NK, Kiszka-Kanowitz M, Rehling M, Henriksen JH, Pedersen EB, Flyvbjerg A, Bendtsen F.
    Hepatology; 2001 Sep 30; 34(3):471-7. PubMed ID: 11526531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.